l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine has been researched along with Glioma in 2 studies
*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugisaki, Y; Takahashi, H; Teramoto, A; Watanabe, K; Yoshida, D | 1 |
| Noha, M; Teramoto, A; Watanabe, K; Yoshida, D | 1 |
2 other study(ies) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Glioma
| Article | Year |
|---|---|
Apoptotic induction by BE16627B on human malignant glioma cell lines by an anti-matrix metalloproteinase agent.
Topics: Apoptosis; Cell Line, Tumor; Dipeptides; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Enzyme Inhibitors; Glioma; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Microscopy, Electron; Succinates | 2003 |
Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.
Topics: Antineoplastic Agents; Collagen Type IV; Coloring Agents; Dipeptides; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Protease Inhibitors; Succinates; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |